As countries are rolling out plans to distribute new vaccines for Covid-19, Canada has to depend on foreign corporations to produce and obtain vaccines. But that has not always been the case - Canada used to have significant capacity to develop and produce important vaccines and drugs. Health policy researcher Colleen Fuller explains how Canada lost that capacity and how it hampers our ability to create a national pharmacare program.